Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-omics study of metformin therapeutic effect and toxicity
ChiCTR1900022997Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Xiangya Hospital, Central South University. Primary endpoints: Urinary metabolites, Plasma metabolites and 2 more. Started May 2019; status: recruiting.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1900022997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022997.